At the forefront of innovation
Nanoimmunotech´s main contribution is to be part of the industry advisory committee to evaluate the real prospects of transfer to the project industry.
The European project studies useful technology against hereditary pathologies.
The technique would allow introducing genes into cells more efficiently and could deactivate the oncogenes that induce the development of cancer.
In the study entitled Gene Therapy Based on Localized Magnetic Hyperthermia for Immunomodulation, collaborates professionals from the Higher Center for Scientific Research of Aragón, the University of Zaragoza and the University of Lisbon and the Medical Oncology group of the Miguel Servet Hospital with advice on its possible clinic application.
The researchers try to generate heat from magnetic nanoparticles with the objective that this temperature opens small pores in the membranes of the cells, through which they could introduce the genetic material.
The study began last September 2017, will last until 2020 and is part of the Research and Innovation program of the European Commission Horizon H2020.